These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22435852)

  • 1. The impact of continuous subcutaneous insulin infusion on glycaemic control in children and adolescents: a regional review in North East England using a bio-modelling approach.
    Sinha A; Thomas MF; Rushton SP; Cheetham T
    Diabet Med; 2012 Oct; 29(10):1342-3. PubMed ID: 22435852
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of glycemic variability in continuous subcutaneous insulin infusion therapy in type 1 diabetes related to anthropometry and complication status.
    Mehdi SK; Hatfield E; Dornhorst A; Oliver NS
    J Diabetes Sci Technol; 2009 Sep; 3(5):1227-8. PubMed ID: 20144442
    [No Abstract]   [Full Text] [Related]  

  • 3. The Percentage of Continuous Subcutaneous Insulin Infusion Usage Among Adult Type 1 Diabetes Mellitus Patients in Japan: A Cross-Sectional Study at National Hospital Organization Hospitals.
    Murata T; Aoki Y; Kato Y; Tanaka T; Araki R; Kato K; Hida K; Kawamura T; Yoshida K; Imamura Y; Toyonaga T; Yamada K; Sakane N;
    J Diabetes Sci Technol; 2017 Sep; 11(5):1055-1056. PubMed ID: 28859515
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
    Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
    Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous subcutaneous insulin infusion in the treatment of children and adolescents with type 1 diabetes mellitus.
    Saha ME; Huuppone T; Mikael K; Juuti M; Komulainen J
    J Pediatr Endocrinol Metab; 2002; 15(7):1005-10. PubMed ID: 12199327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control?
    Shalitin S; Lahav-Ritte T; Lebenthal Y; Devries L; Phillip M
    Diabetes Technol Ther; 2012 May; 14(5):389-97. PubMed ID: 22283639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bolus calculator improves long-term metabolic control and reduces glucose variability in pump-treated patients with Type 1 diabetes.
    Lepore G; Dodesini AR; Nosari I; Scaranna C; Corsi A; Trevisan R
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):e15-6. PubMed ID: 22673770
    [No Abstract]   [Full Text] [Related]  

  • 8. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.
    Bruttomesso D; Farret A; Costa S; Marescotti MC; Vettore M; Avogaro A; Tiengo A; Dalla Man C; Place J; Facchinetti A; Guerra S; Magni L; De Nicolao G; Cobelli C; Renard E; Maran A
    J Diabetes Sci Technol; 2009 Sep; 3(5):1014-21. PubMed ID: 20144414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS).
    New JP; Ajjan R; Pfeiffer AF; Freckmann G
    Diabet Med; 2015 May; 32(5):609-17. PubMed ID: 25661981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Impact of Prolonged Use of Continuous Subcutaneous Insulin Infusion in the Control of Type-1 Diabetes].
    Azevedo S; Saraiva J; Caramelo F; Fadiga L; Barros L; Baptista C; Melo M; Gomes L; Carrilho F
    Acta Med Port; 2019 Feb; 32(1):17-24. PubMed ID: 30753799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous subcutaneous insulin infusion pump treatment in children with type 1 diabetes mellitus.
    Liberatore R; Perlman K; Buccino J; Artiles-Sisk A; Daneman D
    J Pediatr Endocrinol Metab; 2004 Feb; 17(2):223-6. PubMed ID: 15055358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion.
    Weintrob N; Schechter A; Benzaquen H; Shalitin S; Lilos P; Galatzer A; Phillip M
    Arch Pediatr Adolesc Med; 2004 Jul; 158(7):677-84. PubMed ID: 15237068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of continuous subcutaneous insulin infusion (CSII) as the treatment of choice in children and adolescents with type 1 diabetes.
    Battelino T; Ursic-Bratina N; Bratanic N; Zerjav-Tansek M; Avbelj M; Krzisnik C
    Pediatr Endocrinol Rev; 2004 Aug; 1 Suppl 3():537-9. PubMed ID: 16444189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Simplified Approach Using Rate of Change Arrows to Adjust Insulin With Real-Time Continuous Glucose Monitoring.
    Klonoff DC; Kerr D
    J Diabetes Sci Technol; 2017 Nov; 11(6):1063-1069. PubMed ID: 28884599
    [No Abstract]   [Full Text] [Related]  

  • 15. Sustained benefits of continuous subcutaneous insulin infusion.
    Hughes CR; McDowell N; Cody D; Costigan C
    Arch Dis Child; 2012 Mar; 97(3):245-7. PubMed ID: 21109506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NICE guidance on continuous subcutaneous insulin infusion 2008: review of the technology appraisal guidance.
    Pickup JC; Hammond P
    Diabet Med; 2009 Jan; 26(1):1-4. PubMed ID: 19125753
    [No Abstract]   [Full Text] [Related]  

  • 17. Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: decreased HbA1c with low risk of hypoglycemia.
    Sulli N; Shashaj B
    J Pediatr Endocrinol Metab; 2003 Mar; 16(3):393-9. PubMed ID: 12705364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of anxiety and depression on patients within a large type 1 diabetes insulin pump population. An observational study.
    Grant P; Dworakowska D; DeZoysa N; Barnes D
    Diabetes Metab; 2013 Oct; 39(5):439-44. PubMed ID: 24076359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment.
    Lepore G; Dodesini AR; Nosari I; Trevisan R
    Diabetes Care; 2003 Apr; 26(4):1321-2. PubMed ID: 12663625
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors Associated With Glycemic Control During Free-Living Overnight Closed-Loop Insulin Delivery in Children and Adults With Type 1 Diabetes.
    Tauschmann M; Thabit H; Leelarathna L; Elleri D; Allen JM; Lubina-Solomon A; Stadler M; Walkinshaw E; Iqbal A; Choudhary P; Wilinska ME; Heller SR; Amiel SA; Evans ML; Dunger DB; Hovorka R
    J Diabetes Sci Technol; 2015 Oct; 9(6):1346-7. PubMed ID: 26451010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.